Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rabbit Anti-Duck IgG (H+L) Polyclonal Antibody-[Biotin]

Product Overview

BioVenic rabbit polyclonal antibody is specific for duck IgG (H+L). It can be applied to FCM, IF, IP, IHC, ELISA and WB assays of duck IgG (H+L).

Specifications

Application FCM; IF; IP; IHC; ELISA; WB

Clonality Polyclonal

Classification Labeled Antibody

Clone L14N2

Host Rabbit

Target Species Duck

Species Reactivity Duck

Specificity Duck IgG

Purity > 90%

Concentration 1 mg/mL

Conjugation Biotin

Preservative and Stabilizer Sodium Azide

Buffer 0.01M Phosphate Buffered Saline, 0.5% Rabbit Serum Albumin and 50% Glycerol

Physical State Liquid

Target Information

Duck IgG (H+L) is a type of immunoglobulin found in ducks, which plays a significant role in the immune response by binding to antigens and neutralizing or opsonizing them for destruction. It is composed of two heavy chains and two light chains, similar to other IgG antibodies found in mammals. Duck IgG is known for its stability and has been the focus of research for its potential applications in veterinary medicine and biological research.

Target Duck IgG (H+L)

Shipping and Storage

This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid exposure to light. Avoid repeated freezing and thawing as this may denature the antibody.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Mao, Sai, et al. "Virologic and immunologic characteristics in mature ducks with acute duck hepatitis A virus 1 infection." Frontiers in Immunology 8 (2017): 1574.